StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a report published on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and set a $11.00 target price on shares of Onconova Therapeutics in a research note on Thursday, October […]
28.11.2023 - NEWTOWN, Pa., Nov. 28, 2023 (GLOBE NEWSWIRE) - Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today .
StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research note issued to investors on Friday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $11.00 price target on shares of Onconova Therapeutics in a report on […]
Onconova Therapeutics (NASDAQ:ONTX) Coverage Initiated by Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Onconova Therapeutics Third Quarter 2023 Financial Results and Business Update Conference Call.